ACRO Biomedical Co., Ltd. (TPEX: 6748)
Health Care · Biotechnology · TW
NT$179.00
+2.29% today · +119.6% 1Y
ACRO Biomedical Co., Ltd. (TPEX: 6748) operates in the Biotechnology industry within the Health Care sector. The company is valued at $400.34M and employs 42 people.
Over the last twelve months the share price has gained 119.6%, trading between 57.30 and 310.00.
Tweenvest scores ACRO Biomedical Co., Ltd. across four factors: quality 36/100, value 70/100. Its strongest factor is value.
6748 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $400.34M
- Revenue (TTM)
- $1.66M
- P/E
- —
- EPS
- -1.18
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- NT$310.00
- 52-week low
- NT$57.30
- Avg volume (3M)
- —
- Shares outstanding
- 71.22M
- Employees
- 42
- Next earnings
- —
About ACRO Biomedical Co., Ltd.
ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of biomaterial-based medical devices, specifically designed for applications in human tissue engineering and regenerative medicine. This company was established on June 26, 2014, and operates primarily from its headquarters in Kaohsiung, Taiwan.
- ISIN
- TW0006748007
- Founded
- 2014
- Listed since
- Jul 27, 2021
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.